Meet the Awardees

Solving the complexities of pancreatic cancer requires diversity of thought, education, training, background, and experience of the scientists investigating the disease. That is why we are committed to funding the world’s preeminent pancreatic cancer researchers.

Collectively, we have one goal: to transform pancreatic into a curable disease.

Grantee Highlights:

Avery Posey

Avery D. Posey Jr., PhD, Perelman School of Medicine at the University of Pennsylvania
2021 recipient of the Career Development Award in Honor of John Robert Lewis

Dr. Posey focuses on the development of novel cancer therapies for humans and dogs that genetically alter cancer patients’ own T cells to improve the ability of the immune system to fight cancer. Learn more.

Jen Jen Yeh, MD, UNC Lineberger Comprehensive Cancer Center
2022 recipient of the Lustgarten Equity, Accessibility, and Diversity (LEAD) Project grant

Dr. Yeh’s focus is to identify and study novel therapeutic targets for the treatment of colorectal and pancreatic cancer. Her research centers on target identification through genomic analysis of human tumors, validation, drug discovery and finally clinical trials. Learn more.

Laura Wood, MD, PhD, Johns Hopkins University School of Medicine
2022 recipient of Early Events in Pancreatic Cancer Grant

Dr. Wood’s current research focuses on defining the key steps in malignant progression in the pancreas using next generation sequencing and other molecular biology approaches. Learn more.

Mandar Muzumdar, MD, Yale Cancer Center
2022 recipient of the Innovation & Collaboration Program Grant

Dr. Muzumdar’s interest is in understanding the mechanisms by which genetic, environmental, and host factors contribute to cancer initiation, progression, and maintenance. The ultimate goal of this research is to identify novel approaches for cancer prevention and treatment. Learn more.

Thanks for signing up!
Tell us a little more about yourself: